Back Back to portfolio

Inoviv

Inoviv uses a novel technology platform based on targeted proteomics to support pharmaceutical companies with biomarker test development.

inoviv.com

Founded In

2017

Fund

Hoxton III

Headquarters

London, UK

Invested In

2021